CTRI/2022/09/045962
Not yet recruiting
未知
Development and validation of a questionnaire for evaluating the effectiveness of practice of buddhimedhakara gana in students
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Apparently healthy individuals.
- •2\.Students of affiliated educational institutions. 3\.Subjects willing to sign informed consent and participate.
Exclusion Criteria
- •1\.Subjects with any known systemic or mental illness.
- •2\.Subjects who are drop outs from any educational institutions.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Development and validation of a questionnaire for the assessment of sleep in individuals with mild intellectual disabilityslaappatroonSleeppatternNL-OMON40493Erasmus MC, Universitair Medisch Centrum Rotterdam80
Completed
Not Applicable
Development and Validation of a questionnaire for assessing the habit of suppression/hold the Flatus and Defecation reflexCTRI/2022/02/040102ational Institute of Siddha100
Recruiting
Not Applicable
Development and Validation of a Questionnaire to assess Treatment Expectations in Chronic PaiF45.41DRKS00027071niversitätsklinikum Jena250
Not yet recruiting
Not Applicable
Knowledge, Facilitator,Barriers and preferences of physical exercises in Cancer survivorsHealth Condition 1: C800- Disseminated malignant neoplasm, unspecifiedCTRI/2019/07/020212AMAR JYOTI INSTITUTE OF PHYSIOTHERAPY
Recruiting
Not Applicable
Development and validation of a questionnaire to measure medication literacy in patients receiving oral anticancer drugsPatients with oral anticancer drugs, regardless of the exact type of cancerC00-C97Malignant neoplasmsDRKS00034341Pharmazeutisches Institut300